Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASTRO Annual Meeting
Poster Viewing Q&A 5: Lung, Pediatrics, Education
Hall A-B1, Ground Level
1PM
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Poster Q&A
Ehsan Balagamwala, MD
Comprehensive Analysis of Toxicity and Pulmonary Function Tests in Patients Undergoing Repeat Lung Stereotactic Body Radiation Therapy (SBRT) After Initial Lung SBRT
Poster Q&A
Bindu Manyam, MD
Single Fraction SBRT for Stage I Non-Small Cell Lung Cancer: Treatment Outcomes and Effect of Tumor Location on Chest Wall Toxicity
Poster Viewing Q&A 6: CNS, Head and Neck, Sarcoma
Hall A-B1, Ground Level
2:45PM
Poster Q&A
Jonathan Sharrett, MD
Tumor Volume is a Better Predictor of Locoregional Failure than T and N Staging in Larynx Cancer Patients Treated with Definitive Chemoradiation
Poster Q&A
Rupesh Kotecha, MD
Personalized Radiosurgery for Brain Metastasis: Moving beyond Tumor Size in the Modern Stereotactic Radiosurgery Era
Poster Q&A
Charles Leyrer, MD
An Evaluation of Prognostic Factors of Elderly Patients with Low Grade Glioma
Poster Q&A
Taoran Cui, MD
A 7-Year Institutional Experience in Dosimetric Quality Improvement for Oropharyngeal Cancer: Progress to Date
Poster Q&A
Shlomo Koyfman, MD
Refining Risk Stratification in HPV-Related Oropharynx Cancer: Implications for Clinical Trials
Poster Q&A
Matthew Ward, MD
One-Size Does Not Fit All: Planning Objectives with IG-VMAT for Oropharynx Cancer and Guidelines by Clinical Context
Poster Viewing Q&A 7: GI, Patient Safety, Hematologic
Hall A-B1, Ground Level
4:45PM
Poster Q&A
Timothy Meier
Presimulation Procedure Safety Checklist/Time Out Reduces Simulation Related Unintended Deviations
Poster Q&A
Ehsan Balagamwala, MD
Intraoperative Radiation Therapy for the Treatment of Locally Advanced and Recurrent Abdominopelvic Tumors
Advertisement
Poster Q&A
Ehsan Balagamwala, MD
T1N0 Esophageal Cancer: A Patterns of Care and Survival Analysis
Poster Q&A
Camille Berriochoa, MD
The Role of Adjuvant Therapy for Patients with Early Esophageal Cancer Who Are Pathologically Upstaged Following Esophagectomy: An NCDB Analysis
Poster Q&A
Camille Berriochoa, MD
Definitive Radiation Therapy for Patients with Metastatic Esophageal Squamous Cell Carcinoma Improves Survival: An NCDB Analysis
Poster Q&A
Charles Leyrer, MD
The Importance of Standardization in Workflow Enhancement and Patient Safety
Poster Q&A
Ping Xia, PhD
Intersystem variability of Kilovoltage Conebeam Computed Tomography Imaging Guidance for Patients with Head and Neck Cancer: An NRG Oncology Multiple Institution study
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust